BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22845427)

  • 1. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL; Chow KL; Looi JL; Lee M; Halliday S; White H; Ellis C
    N Z Med J; 2011 Sep; 124(1343):18-27. PubMed ID: 21964009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based prescribing of drugs for secondary prevention of acute coronary syndrome in Aboriginal and non-Aboriginal patients admitted to Western Australian hospitals.
    Gausia K; Katzenellenbogen JM; Sanfilippo FM; Knuiman MW; Thompson PL; Hobbs MS; Thompson SC
    Intern Med J; 2014 Apr; 44(4):353-61. PubMed ID: 24528930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an acute coronary syndrome pathway in achieving target heart rate and utilization of evidence-based doses of beta-blockers.
    Irani F; Herial N; Colyer WR
    Am J Ther; 2012 Nov; 19(6):397-402. PubMed ID: 21317621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservatively.
    Dziewierz A; Siudak Z; Rakowski T; Mielecki W; Giszterowicz D; Dubiel JS; Dudek D
    Coron Artery Dis; 2007 Jun; 18(4):299-303. PubMed ID: 17496494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaysia-ACute CORonary syndromes Descriptive study (ACCORD): evaluation of compliance with existing guidelines in patients with acute coronary syndrome.
    Ahmad WA; Ramesh SV; Zambahari R
    Singapore Med J; 2011 Jul; 52(7):508-11. PubMed ID: 21808962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study.
    Pedone C; Di Pasquale G; Greco C; Gonzini L; Maggioni AP; Pavesi PC; Sabini A; Boccanelli A;
    Acute Card Care; 2009; 11(4):222-8. PubMed ID: 19995261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.
    Somma KA; Bhatt DL; Fonarow GC; Cannon CP; Cox M; Laskey W; Peacock WF; Hernandez AF; Peterson ED; Schwamm L; Saxon LA
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):654-61. PubMed ID: 22949493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute coronary syndromes in Maghreb countries: The ACCESS (ACute Coronary Events - a multinational Survey of current management Strategies) registry.
    Moustaghfir A; Haddak M; Mechmeche R
    Arch Cardiovasc Dis; 2012 Nov; 105(11):566-77. PubMed ID: 23177485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.